Mortality data backs HRT safety

There is "compelling and reassuring" mortality data to back the safety of HRT, according to a re-analysis of the controversial Women's Health Initiative (WHI) trials, say researchers.

While there has been much debate about HRT's impact on individual disease outcomes, a study in JAMA shows that short-term use is not linked to an increase in all-cause or disease-specific mortality.

Harvard Medical School researchers assessed mortality outcomes in 27,000 women who used HRT for an average of 5.6 years, and found no difference in all-cause mortality between